(Q74296343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J J Vinholes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

O P Purohit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M E Abbey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R E Coleman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1243-1250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

High-dose intravenous pamidronate for metastatic bone pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Assessment of response of bone metastases to systemic treatment in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Biochemical prediction of response of bone metastases to treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Pyridinium crosslinks as markers of bone resorption in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

[Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases]

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Early morning hydroxyproline excretion in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Metabolic effects of pamidronate in patients with metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008238422151

7 January 2021

Identifiers

DOI

10.1023/A:1008238422151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9496390%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference